Optimizing Treatment of Chronic Lymphocytic Leukemia

During JADPRO Live Virtual 2020, Sandra Kurtin, PhD, ANP-C, AOCN®, described personalization of the treatment of chronic lymphocytic leukemia (CLL) using molecular attributes of the disease, as well as patient characteristics. Dr. Kurtin discussed front-line treatment in previously untreated patient...

Descripción completa

Detalles Bibliográficos
Autor principal: Kurtin, Sandra E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2021
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087240/
https://www.ncbi.nlm.nih.gov/pubmed/34084585
http://dx.doi.org/10.6004/jadpro.2021.12.3.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087240/
https://www.ncbi.nlm.nih.gov/pubmed/34084585
http://dx.doi.org/10.6004/jadpro.2021.12.3.23

Ejemplares similares